Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Haemonetics Corp 125 Summer Street Boston MA 02110 USA

www.haemonetics.com Employees: 3,657 P: 781-848-7100 F: 781-356-9956

Description:

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.

Key Statistics

Overview:

Market Capitalization, $K 4,480,985
Enterprise Value, $K 5,099,745
Shares Outstanding, K 50,224
Annual Sales, $ 1,309 M
Annual Net Income, $ 117,560 K
Last Quarter Sales, $ 345,510 K
Last Quarter Net Income, $ 33,830 K
EBIT, $ 207,450 K
EBITDA, $ 311,190 K
60-Month Beta 0.32
% of Insider Shareholders 1.80%
% of Institutional Shareholders 99.67%
Float, K 49,320
% Float 98.20%
Short Volume Ratio 0.80

Growth:

1-Year Return 5.96%
3-Year Return 58.84%
5-Year Return -24.59%
5-Year Revenue Growth 35.29%
5-Year Earnings Growth 65.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.12 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm 4.08
EPS Growth vs. Prev Qtr 9.80%
EPS Growth vs. Prev Year 13.13%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 12/03/12

HAE Ratios

Ratio
Price/Earnings ttm 22.24
Price/Earnings forward 19.79
Price/Earnings to Growth 1.41
Return-on-Equity % 22.66%
Return-on-Assets % 8.83%
Profit Margin % 8.98%
Debt/Equity 1.39
Price/Sales 3.48
Price/Cash Flow 14.99
Price/Book 5.28
Book Value/Share 17.17
Interest Coverage 12.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar